No retraction, correction or concern found when last checked on Oct 30, 2026.
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao, Inna Goreshnik, Brian Coventry and 12 more
Science · 2020 · CC BY
Abstract
Miniproteins against SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is decorated with spikes, and viral entry into cells is initiated when these spikes bind to the host angiotensin-converting enzyme 2 (ACE2) receptor. Many monoclonal antibody therapies in development target the spike proteins. Cao et al. designed small, stable proteins that bind tightly to the spike and block it from binding to ACE2. The best designs bind with very high affinity and prevent SARS-CoV-2 infection of mammalian Vero E6 cells. Cryo–electron microscopy shows that the structures of the two most potent inhibitors are nearly identical to the computational models. Unlike antibodies, the miniproteins do not require expression in mammalian cells, and their small size and high stability may allow formulation for direct delivery to the nasal or respiratory system. Science , this issue p. 426
References 39
- 1.
Y. J. Hou, K. Okuda, C. E. Edwards, D. R. Martinez, T. Asakura, K. H. Dinnon 3rd, T. Kato, R. E. Lee, B. L. Yount, T. M. Mascenik, G. Chen, K. N. Olivier, A. Ghio, L. V. Tse, S. R. Leist, L. E. Gralinski, A. Schäfer, H. Dang, R. Gilmore, S. Nakano, L. Sun, M. L. Fulcher, A. Livraghi-Butrico, N. I. Nicely, M. Cameron, C. Cameron, D. J. Kelvin, A. de Silva, D. M. Margolis, A. Markmann, L. Bartelt, R. Zumwalt, F. J. Martinez, S. P. Salvatore, A. Borczuk, P. R. Tata, V. Sontake, A. Kimple, I. Jaspers, W. K. O’Neal, S. H. Randell, R. C. Boucher, R. S. Baric, SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429–446.e14 (2020 ).
Not in our library10.1016/j.cell.2020.05.042
- 2.
R. Shi, C. Shan, X. Duan, Z. Chen, P. Liu, J. Song, T. Song, X. Bi, C. Han, L. Wu, G. Gao, X. Hu, Y. Zhang, Z. Tong, W. Huang, W. J. Liu, G. Wu, B. Zhang, L. Wang, J. Qi, H. Feng, F. S. Wang, Q. Wang, G. F. Gao, Z. Yuan, J. Yan, A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120–124 (2020 ).
Not in our library10.1038/s41586-020-2381-y
- 3.
D. Pinto, Y.-J. Park, M. Beltramello, A. C. Walls, M. A. Tortorici, S. Bianchi, S. Jaconi, K. Culap, F. Zatta, A. De Marco, A. Peter, B. Guarino, R. Spreafico, E. Cameroni, J. B. Case, R. E. Chen, C. Havenar-Daughton, G. Snell, A. Telenti, H. W. Virgin, A. Lanzavecchia, M. S. Diamond, K. Fink, D. Veesler, D. Corti, Structural and functional analysis of a potent sarbecovirus neutralizing antibody. bioRxiv 023903 [Preprint] 10 April 2020;.
Not in our library10.1101/2020.04.07.023903
- 4.
J. Lan, J. Ge, J. Yu, S. Shan, H. Zhou, S. Fan, Q. Zhang, X. Shi, Q. Wang, L. Zhang, X. Wang, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220 (2020 ).
Not in our library10.1038/s41586-020-2180-5
- 5.
M. Yuan, N. C. Wu, X. Zhu, C. D. Lee, R. T. Y. So, H. Lv, C. K. P. Mok, I. A. Wilson, A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630–633 (2020 ).
Not in our library10.1126/science.abb7269
- 6.
- 7.
K. L. Winarski, J. Tang, L. Klenow, J. Lee, E. M. Coyle, J. Manischewitz, H. L. Turner, K. Takeda, A. B. Ward, H. Golding, S. Khurana, Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics. Proc. Natl. Acad. Sci. U.S.A. 116, 15194–15199 (2019 ).
Not in our library10.1073/pnas.1821317116
- 8.
A. Taylor, S.-S. Foo, R. Bruzzone, L. V. Dinh, N. J. C. King, S. Mahalingam, Fc receptors in antibody-dependent enhancement of viral infections. Immunol. Rev. 268, 340–364 (2015 ).
Not in our library10.1111/imr.12367
- 9.
B. S. Graham, Rapid COVID-19 vaccine development. Science 368, 945–946 (2020 ).
Not in our library10.1126/science.abb8923
- 10.
A. C. Walls, Y.-J. Park, M. A. Tortorici, A. Wall, A. T. McGuire, D. Veesler, Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. bioRxiv 956581 [Preprint] 20 February 2020..
Not in our library10.1101/2020.02.19.956581
- 11.
A. Chevalier, D. A. Silva, G. J. Rocklin, D. R. Hicks, R. Vergara, P. Murapa, S. M. Bernard, L. Zhang, K. H. Lam, G. Yao, C. D. Bahl, S. I. Miyashita, I. Goreshnik, J. T. Fuller, M. T. Koday, C. M. Jenkins, T. Colvin, L. Carter, A. Bohn, C. M. Bryan, D. A. Fernández-Velasco, L. Stewart, M. Dong, X. Huang, R. Jin, I. A. Wilson, D. H. Fuller, D. Baker, Massively parallel de novo protein design for targeted therapeutics. Nature 550, 74–79 (2017 ).
Not in our library10.1038/nature23912
- 12.
J. Dou, A. A. Vorobieva, W. Sheffler, L. A. Doyle, H. Park, M. J. Bick, B. Mao, G. W. Foight, M. Y. Lee, L. A. Gagnon, L. Carter, B. Sankaran, S. Ovchinnikov, E. Marcos, P. S. Huang, J. C. Vaughan, B. L. Stoddard, D. Baker, De novo design of a fluorescence-activating β-barrel. Nature 561, 485–491 (2018 ).
Not in our library10.1038/s41586-018-0509-0
- 13.
W. B. Alsoussi, J. S. Turner, J. B. Case, H. Zhao, A. J. Schmitz, J. Q. Zhou, R. E. Chen, T. Lei, A. A. Rizk, K. M. McIntire, E. S. Winkler, J. M. Fox, N. M. Kafai, L. B. Thackray, A. O. Hassan, F. Amanat, F. Krammer, C. T. Watson, S. H. Kleinstein, D. H. Fremont, M. S. Diamond, A. H. Ellebedy, A potently neutralizing antibody protects mice against SARS-CoV-2 infection. J. Immunol. 205, 915–922 (2020 ).
Not in our library10.4049/jimmunol.2000583
- 14.
D. A. Silva, S. Yu, U. Y. Ulge, J. B. Spangler, K. M. Jude, C. Labão-Almeida, L. R. Ali, A. Quijano-Rubio, M. Ruterbusch, I. Leung, T. Biary, S. J. Crowley, E. Marcos, C. D. Walkey, B. D. Weitzner, F. Pardo-Avila, J. Castellanos, L. Carter, L. Stewart, S. R. Riddell, M. Pepper, G. J. L. Bernardes, M. Dougan, K. C. Garcia, D. Baker, De novo design of potent and selective mimics of IL-2 and IL-15. Nature 565, 186–191 (2019 ).
Not in our library10.1038/s41586-018-0830-7
- 15.
J. Shang, G. Ye, K. Shi, Y. Wan, C. Luo, H. Aihara, Q. Geng, A. Auerbach, F. Li, Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224 (2020 ).
Not in our library10.1038/s41586-020-2179-y
- 16.
Q. Wang, Y. Zhang, L. Wu, S. Niu, C. Song, Z. Zhang, G. Lu, C. Qiao, Y. Hu, K. Y. Yuen, Q. Wang, H. Zhou, J. Yan, J. Qi, Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894–904.e9 (2020 ).
Not in our library10.1016/j.cell.2020.03.045
- 17.
- 18.
- 19.
N. Koga, R. Tatsumi-Koga, G. Liu, R. Xiao, T. B. Acton, G. T. Montelione, D. Baker, Principles for designing ideal protein structures. Nature 491, 222–227 (2012 ).
Not in our library10.1038/nature11600
- 20.
D. M. Hoover, J. Lubkowski, DNAWorks: An automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res. 30, e43 (2002 ).
Not in our library10.1093/nar/30.10.e43
- 21.
- 22.
C. Suloway, J. Pulokas, D. Fellmann, A. Cheng, F. Guerra, J. Quispe, S. Stagg, C. S. Potter, B. Carragher, Automated molecular microscopy: The new Leginon system. J. Struct. Biol. 151, 41–60 (2005 ).
Not in our library10.1016/j.jsb.2005.03.010
- 23.
D. Tegunov, P. Cramer, Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146–1152 (2019 ).
Not in our library10.1038/s41592-019-0580-y
- 24.
A. Punjani, J. L. Rubinstein, D. J. Fleet, M. A. Brubaker, cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017 ).
Not in our library10.1038/nmeth.4169
- 25.
- 26.
- 27.
A. Punjani, H. Zhang, D. J. Fleet, Non-uniform refinement: Adaptive regularization improves single particle cryo-EM reconstruction. bioRxiv 877092 [Preprint] 16 December 2019..
Not in our library10.1101/2019.12.15.877092
- 28.
- 29.
- 30.
E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004 ).
Not in our library10.1002/jcc.20084
- 31.
- 32.
B. Frenz, S. Rämisch, A. J. Borst, A. C. Walls, J. Adolf-Bryfogle, W. R. Schief, D. Veesler, F. DiMaio, Automatically fixing errors in glycoprotein structures with Rosetta. Structure 27, 134–139.e3 (2019 ).
Not in our library10.1016/j.str.2018.09.006
- 33.
F. DiMaio, Y. Song, X. Li, M. J. Brunner, C. Xu, V. Conticello, E. Egelman, T. Marlovits, Y. Cheng, D. Baker, Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement. Nat. Methods 12, 361–365 (2015 ).
Not in our library10.1038/nmeth.3286
- 34.
- 35.
C. J. Williams, J. J. Headd, N. W. Moriarty, M. G. Prisant, L. L. Videau, L. N. Deis, V. Verma, D. A. Keedy, B. J. Hintze, V. B. Chen, S. Jain, S. M. Lewis, W. B. Arendall 3rd, J. Snoeyink, P. D. Adams, S. C. Lovell, J. S. Richardson, D. C. Richardson, MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018 ).
Not in our library10.1002/pro.3330
- 36.
- 37.
J. Agirre, J. Iglesias-Fernández, C. Rovira, G. J. Davies, K. S. Wilson, K. D. Cowtan, Privateer: Software for the conformational validation of carbohydrate structures. Nat. Struct. Mol. Biol. 22, 833–834 (2015 ).
Not in our library10.1038/nsmb.3115
- 38.
B. A. Barad, N. Echols, R. Y.-R. Wang, Y. Cheng, F. DiMaio, P. D. Adams, J. S. Fraser, EMRinger: Side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943–946 (2015 ).
Not in our library10.1038/nmeth.3541
- 39.
T. D. Goddard, C. C. Huang, E. C. Meng, E. F. Pettersen, G. S. Couch, J. H. Morris, T. E. Ferrin, UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018 ).
Not in our library10.1002/pro.3235
Cited by papers we hold 10
- Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron · 2025Not checked
- Designed endocytosis-inducing proteins degrade targets and amplify signals · 2024No notice
- The JAK-STAT pathway: from structural biology to cytokine engineering · 2024Corrected
- De novo design of protein interactions with learned surface fingerprints · 2023No notice
- Engineering protein-based therapeutics through structural and chemical design · 2023No notice
- Design of protein-binding proteins from the target structure alone · 2022No notice
- Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy · 2021No notice
- Antibody-guided design and identification of CD25-binding small antibody mimetics using mammalian cell surface display · 2021Not checked
- Recent advances in de novo protein design: Principles, methods, and applications · 2021No notice
- De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.